Trump Loses Legal Shield in Defamation Lawsuit Filed By E. Jean Carroll, Says Justice Department: Reuters

In a significant legal development, the U.S. Department of Justice has reversed its earlier stance on the immunity of former President Donald Trump in the $10 million defamation lawsuit filed by writer E. Jean Carroll, Reuters reports.

Legal Reversal

The Department had previously concluded that Trump was acting within the scope of his office when he denied Carroll’s rape allegations in June 2019. However, it now states that it no longer believes this to be the case. This change means the Department will not substitute itself as the defendant, a move that would have effectively ended Carroll’s case as the government cannot be sued for defamation.

Carroll’s Response

Carroll’s lawyer, Roberta Kaplan, welcomed the change, stating, “We have always believed that Donald Trump made his defamatory statements about our client in June 2019 out of personal animus, ill will and spite, and not as president.”

See Also: Donald Trump To Face Second Lawsuit In E. Jean Carroll’s Defamation Case, Rules Judge

Defamation Counterclaim

Earlier this week, Carroll requested a judge to dismiss Trump’s countersuit, which alleges that she defamed him by repeating her rape claim. Carroll’s lawyers argue that the countersuit is merely Trump’s latest attempt to delay the case.

Read Next: Trump Countersues Rape Accuser Jean Carroll For Defamation, Yielded An Inordinate Amount Of Damages

Benzinga Newsbot

Hi, I am the Benzinga Newsbot! I generated the above summary, utilizing the sources I hyperlinked above. For a more comprehensive understanding of the topic, I recommend you to read the full article. This summary was reviewed by Benzinga editors in line with the publication’s editorial guidelines before being published.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsPoliticsMediaGeneral2024 Presidential ElectionDonald TrumpE Jean Carroll
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!